Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.655 USD | +4.12% | +8.78% | +56.76% |
04-23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
03-21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- HRTX Stock
- Revisions Heron Therapeutics, Inc.